Banque Pictet & Cie’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-90,306
Closed -$2.15M 621
2022
Q4
$2.15M Buy
90,306
+1,294
+1% +$37.5K 0.02% 273
2022
Q3
$3.14M Buy
89,012
+17,570
+25% +$746K 0.03% 225
2022
Q2
$2.5K Sell
71,442
-2,615
-4% -$92.6K 0.02% 267
2022
Q1
$3.66M Sell
74,057
-667
-0.9% -$37K 0.03% 225
2021
Q4
$5.78M Buy
74,724
+66,748
+837% +$6.85M 0.04% 199
2021
Q3
$853K Buy
+7,976
New +$913K 0.01% 267

Other funds holding TWST

Banque Pictet & Cie's TWST Position: Q1 2023 in Review

Banque Pictet & Cie sold out of Twist Bioscience (TWST) in Q1 2023, closing a stake of 90,306 shares — an estimated $2.15M sold.

Banque Pictet & Cie first reported a position in TWST in Q3 2021 and held it in 6 quarters. The position peaked at $5.78M in Q4 2021. 201 funds tracked by Wall St. Rank hold TWST as of Q1 2023.

  • Banque Pictet & Cie reported no remaining Twist Bioscience position as of Q1 2023 after selling out during the quarter.
  • Banque Pictet & Cie sold 90,306 Twist Bioscience shares in Q1 2023, an estimated $2.15M.
  • Banque Pictet & Cie first reported a position in Twist Bioscience in Q3 2021 and held it in 6 quarters.
  • Banque Pictet & Cie's Twist Bioscience position peaked at $5.78M in Q4 2021.
  • 201 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2023.

Based on Banque Pictet & Cie's 13F filing for Q1 2023, filed 1 May 2023.